These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 8649650)
21. Beneficial effect of neutrophil elastase inhibitor on anti-Thy1.1 nephritis in rats. Kumasaka R; Nakamura N; Fujita T; Murakami R; Shimada M; Osawa H; Yamabe H; Okumura K Nephrology (Carlton); 2008 Feb; 13(1):27-32. PubMed ID: 18199098 [TBL] [Abstract][Full Text] [Related]
22. Single and multiple drug therapy in autologous immune complex nephritis in rats. Kupor LR; Lowance DC; McPhaul JJ J Lab Clin Med; 1976 Jan; 87(1):27-36. PubMed ID: 128575 [TBL] [Abstract][Full Text] [Related]
23. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors. Silva FG; Hoyer JR; Pirani CL Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880 [TBL] [Abstract][Full Text] [Related]
24. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498 [TBL] [Abstract][Full Text] [Related]
25. Contribution of ED-1- and CD-8-positive cells to the development of crescentic-type anti-GBM nephritis in rats. Hattori T; Nagamatsu T; Ito M; Suzuki Y Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1228-39. PubMed ID: 7853754 [TBL] [Abstract][Full Text] [Related]
26. Reactive oxygen products in heterologous anti-glomerular basement membrane nephritis in rats. Birtwistle RJ; Michael J; Howie AJ; Adu D Br J Exp Pathol; 1989 Apr; 70(2):207-13. PubMed ID: 2786425 [TBL] [Abstract][Full Text] [Related]
27. Antifibrinolytics in cardiac surgery. Dhir A Ann Card Anaesth; 2013; 16(2):117-25. PubMed ID: 23545866 [TBL] [Abstract][Full Text] [Related]
28. [Studies on antinephritic effect of lipo PGE1 (1). Effect of lipo PGE1 on crescentic-type anti-GBM nephritis in rats]. Nagao T; Hattori T; Ito M; Suzuki Y Nihon Jinzo Gakkai Shi; 1991 Mar; 33(3):247-56. PubMed ID: 2062010 [TBL] [Abstract][Full Text] [Related]
29. Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass. Dorman BH; Stroud RE; Wyckoff MM; Zellner JL; Botta D; Leonardi AH; Ikonomidis JS; Spinale FG J Cardiovasc Pharmacol; 2008 Apr; 51(4):418-23. PubMed ID: 18427286 [TBL] [Abstract][Full Text] [Related]
30. Clinical application of inhibitors of fibrinolysis. Verstraete M Drugs; 1985 Mar; 29(3):236-61. PubMed ID: 2580684 [TBL] [Abstract][Full Text] [Related]
31. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost. Ray MJ; O'Brien MF Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462 [TBL] [Abstract][Full Text] [Related]
32. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430 [TBL] [Abstract][Full Text] [Related]
33. Therapeutic effect of all-trans-retinoic acid (at-RA) on an autoimmune nephritis experimental model: role of the VLA-4 integrin. Escribese MM; Conde E; Martín A; Sáenz-Morales D; Sancho D; Pérez de Lema G; Lucio-Cazaña J; Sánchez-Madrid F; García-Bermejo ML; Mampaso FM BMC Nephrol; 2007 Jan; 8():3. PubMed ID: 17250768 [TBL] [Abstract][Full Text] [Related]
34. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid. Greilich PE; Okada K; Latham P; Kumar RR; Jessen ME Circulation; 2001 Sep; 104(12 Suppl 1):I265-9. PubMed ID: 11568067 [TBL] [Abstract][Full Text] [Related]
35. [Effects of reactive oxygen species scavenger and platelet activating factor receptor antagonist on accelerated nephrotoxic nephritis]. Kakuta S Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):115-24. PubMed ID: 8315875 [TBL] [Abstract][Full Text] [Related]
36. [Pharmacological studies on experimental nephritic rats (13). The development and aggravation of nephritis due to the repeated administration of liquoid (author's transl)]. Ito M; Yokochi E; Kito T; Suzuki Y Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):419-25. PubMed ID: 6269971 [TBL] [Abstract][Full Text] [Related]
37. Pirfenidone and candesartan ameliorate morphological damage in mild chronic anti-GBM nephritis in rats. Leh S; Vaagnes Ø; Margolin SB; Iversen BM; Forslund T Nephrol Dial Transplant; 2005 Jan; 20(1):71-82. PubMed ID: 15561744 [TBL] [Abstract][Full Text] [Related]
38. Chemical and histochemical studies of glomerular sialoprotein in nephrotoxic nephritis in rats. Chiu J; Drummond KN Am J Pathol; 1972 Aug; 68(2):391-406. PubMed ID: 4114975 [TBL] [Abstract][Full Text] [Related]
39. [Production of reactive oxygen species and scavenger treatment in nephrotoxic nephritis]. Nakamura K Nihon Jinzo Gakkai Shi; 1992 Jul; 34(7):761-72. PubMed ID: 1479715 [TBL] [Abstract][Full Text] [Related]
40. Antiproteinuric effect of pirfenidone in a rat model of anti-glomerular basement membrane glomerulonephritis. Takakura K; Mizukami K; Mitori H; Noto T; Tomura Y Eur J Pharmacol; 2014 Aug; 737():106-16. PubMed ID: 24858365 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]